The outcome of the U.S. presidential election could significantly influence venture investing, particularly concerning regulations and tax changes that impact sectors like AI and biopharma. Investors are particularly focused on antitrust issues, as a more lenient regulatory environment is seen as necessary for a healthier M&A market. The failure of deals like the $1.4 billion acquisition has heightened concerns. Crypto is also a focal point, with candidates' stances on regulation being closely monitored amid substantial campaign contributions from the crypto community. Concerns regarding tax policies, especially the renewal of the 2017 tax deduction for R&D expenses, are critical for startups. Furthermore, potential healthcare regulations that affect biotech are under scrutiny. Overall, while the presidential election is crucial, local and state regulations also play a significant role in shaping the venture landscape. Investors generally prefer minimal government interference to foster growth and efficiency in the industry.

Source 🔗